Skip to main content
OpenTrials

Clinical trial condition

Hemic and Lymphatic Diseases

Explore clinical trials studying Hemic and Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

21,079 public trials 3,991 recruiting studies
Refine in advanced search Browse all conditions

Hemic and Lymphatic Diseases trial results

Recruiting

Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis

NCT00315380

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +13 more
Locations
  • University of California San Diego San Diego, California, United States
  • National Jewish Health Denver, Colorado, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
View all 15 locations
View Trial Details
Recruiting

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

NCT07258511

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • UAMS Little Rock, Arkansas, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
View all 144 locations
View Trial Details
Recruiting

A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

NCT06533098

Conditions
Blood Platelet Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cytopenia, +5 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • UC Davis School of Medicine Sacramento, California, United States
  • Childrens Hospital Colorado Aurora, Colorado, United States
  • Advocate Children's Hospital Park Ridge, Illinois, United States
View all 28 locations
View Trial Details
Recruiting

Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies

NCT07284433

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations
  • University of Chicago Chicago, Illinois, United States
  • Northwestern University Evanston, Illinois, United States
  • Brown University Health Providence, Rhode Island, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
View all 13 locations
View Trial Details
Recruiting

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

NCT05201781

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Mayo Clinic Cancer Center-Scottsdale Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Stanford University Medical Center Stanford, California, United States
View all 50 locations
View Trial Details
Recruiting

A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

NCT06449651

Conditions
Blood Platelet Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cytopenia, +5 more
Locations
  • Universitair Ziekenhuis Leuven Leuven, Belgium
  • Instituto de Medicina Integral Professor Fernando Figueira Recife, Brazil
  • Hospital Das Clinicas Da Faculdade De Medicina Da USP São Paulo, Brazil
  • CHRU Lille Lille, France
View all 21 locations
View Trial Details
Recruiting

A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies

NCT07572006

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +2 more
Locations
  • Indiana Blood & Marrow Transplantation Indianapolis, Indiana, United States
  • Start Midwest Grand Rapids, Michigan, United States
  • Rutgers Cancer Institute of New Jersey Piscataway, New Jersey, United States
  • NYU Langone Health New York, United States
View all 15 locations
View Trial Details

Related conditions